Results 201 to 210 of about 12,597 (249)

Molecular Mechanisms of Efficacy Variation in Antivenoms: Insights from a Malayan Pit Viper (<i>Calloselasma rhodostoma</i>) Bite in Vietnam. [PDF]

Trop Med Infect Dis
Le TQ, Nguyen NT, Pham YB, Vu MB, Le NT, Nguyen NSP, Balchan NR, Tan CH, Duong TH, Nguyen HH, Nguyen TT.   +10 more
europepmc   +1 more source

"Survey on the burden, epidemiological and clinical characteristics of snakebite envenoming in the Health Demographic Surveillance System (HDSS) of Taabo (Southern Côte d'Ivoire)". [PDF]

PLoS Negl Trop Dis
N'Krumah TASR, Koné BV, Koffi YD, Coulibaly DI, Tall A, Koné S, Toppino S, Stojkovic M, Bonfoh B, Junghanss T.   +9 more
europepmc   +1 more source

Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romani. [PDF]

PLoS Negl Trop Dis
Edge RJ, Marriott AE, Keen M, Xie T, Crittenden EP, Dawson CA, Wilkinson MC, Wüster W, Casewell NR, Ainsworth S, Menzies SK.   +10 more
europepmc   +1 more source

Clinical Characteristics of Snakebite Envenomings in Taiwan. [PDF]

Toxins (Basel)
Mao YC, Liu PY, Lai KL, Luo Y, Chen KT, Lai CS.   +5 more
europepmc   +1 more source

Effectiveness of late and very late antivenom administration on recovery from snakebite-induced coagulopathy in French Guiana: a population-based study. [PDF]

Lancet Reg Health Am
Pujo JM, Houcke S, Lontsi Ngoulla GR, Laurent V, Signaté B, Mutricy R, Frémery A, Nkontcho F, Ben Amara I, Gutiérrez JM, Resiere D, Kallel H.   +11 more
europepmc   +1 more source

Unveiling the burden of snakebite injuries: an EQ-5D-5 L-based evaluation of health-related quality of life. [PDF]

BMC Public Health
Tian X, Yan S, Lv C, Song X, Wang J, Hao W, He L, Chen Y, Hu Y.   +8 more
europepmc   +1 more source

Markers of cardiac injury in patients who are victims of bothrops envenomation

Maria da Conceição Rodrigues Gonçalves da [UNIFESP] Costa, http://lattes.cnpq.br/7491476803448979   +1 more
openalex   +1 more source

A drug combination therapy consisting of toxin phospholipase A2 and metalloproteinase inhibitors provides preclinical protection against North American Crotalid snakebite envenoming

Dawson CA, Marriott AE, Crittenden E, Westhorpe A, Stars E, Edge RJ, Hall SR, Menzies SK, Clare RH, Casewell NR.   +9 more
europepmc   +1 more source